Body Composition Research
CJC-1295 No-DAC
A growth hormone–releasing hormone analog studied in GH pathway research models.
Mechanism Overview
CJC-1295 No-DAC (mod GRF 1-29) is studied in preclinical research for its relationship to growth hormone–releasing hormone receptor signaling and downstream pulsatile growth hormone release.
Research Interest Areas
- GH pathway research
- Body composition research
- Recovery adjacent research
Disclaimer
This product is sold strictly for research use only. It is not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.
Related Compounds · Body Composition Research
Retatrutide
A research compound studied in metabolic signaling and body composition research models.
Tesamorelin
Studied in models of growth hormone–releasing pathways and visceral lipid signaling.
CJC-1295 / Ipamorelin
A widely studied pairing in growth hormone–releasing pathway and ghrelin receptor research.